← Back to Clinical Trials
Recruiting NCT02988128

Neurovascular Product Surveillance Registry

Trial Parameters

Condition Intracranial Aneurysm
Sponsor Medtronic Neurovascular Clinical Affairs
Study Type OBSERVATIONAL
Phase N/A
Enrollment 4,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2016-12
Completion 2032-08
Interventions
Treatment for intracranial aneurysmsTreatment for Acute Ischemic Stroke

Brief Summary

Post market surveillance registry

Eligibility Criteria

For MDT16056 and MDT17077 Inclusion Criteria: * Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements * Patient has, or is intended to receive or be treated with, an eligible Medtronic product * Patient is consented within the enrollment window of the therapy received, as applicable * Patient is at least 18 years of age at time of enrollment. Exclusion Criteria: * Patient who is, or is expected to be inaccessible for follow-up * Patient with exclusion criteria required by local law * Patient is currently enrolled in or plans to enroll in any concurrent drug and/or device study that may confound results * Female patient who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study. For MDT24028 and MDT22032: General Inclusion Criteria: * Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical r

Related Trials